Study links fine particulate matter exposure to increased risk of gestational diabetes

Researchers assesses the relationship between exposure to fine particulate matter and the risk of gestational diabetes mellitus.

Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials

Tumor vaccines can help the body fight cancer. These vaccines alert the patient’s immune system to proteins that are carrying cancer-typical alterations.

September 22, 2023

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Cyto-Mine Chroma enhances single-cell analysis with advanced multiplexing and assay flexibility, optimizing functional screening workflows for researchers.

October 1, 2024

Iovance’s registrational lung cancer trial on hold after patient death

The FDA placed a clinical hold on a registrational trial of Iovance Biotherapeutics’ tumor-infiltrating lymphocyte, or TIL, therapy LN-145 after a patient death in the

December 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.